At the administered dose (1 mg/kg) in this study, ST909 significantly activated the STING-IRF3 pathway during cerebral ischemia, which releases IFN-β, promoting angiogenesis and oxidative stress resistance. This evidence concerns the gene IFNB1 and brain ischemia.